Every S-1 that Cyabra, Inc. (CYAB) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A S-1 covers the registration statement a company files to sell shares publicly, so if you follow CYAB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CYAB filings page.
Cyabra, Inc. (CYAB) registers for resale by selling shareholders up to 21,466,410 shares of Common Stock: 14,347,968 shares issuable upon exercise of Pre-Funded Warrants and 7,118,442 shares issuable upon exercise of Series B Warrants. Selling shareholders may not sell these securities under the prospectus until the registration statement is effective. The Pre-Funded Warrants have a $0.0001-per-share exercise price and are exercisable immediately; the Series B Warrants have a $0.45-per-share exercise price, became exercisable on September 2, 2026, and expire twelve months from the initial exercise date.
Cyabra will receive no proceeds from selling-shareholder resales. If all of the covered warrants are exercised for cash, Cyabra may receive up to approximately $3.2 million for working capital and other general corporate purposes. The underlying PIPE closed on July 10, 2026, with approximately $6 million in gross proceeds before placement-agent fees and offering expenses. The prospectus states that the shares offered equal approximately 61.7% of 34,784,611 Common Stock shares outstanding as of October 7, 2026; the last reported sale price was $0.20 per share on October 6, 2026.
Cyabra, Inc. (CYAB) is registering for resale up to 21,645,176 shares of common stock, all to be sold from time to time by existing selling shareholders, primarily from a July 2026 PIPE financing and conversions of preferred stock. The company itself is not selling shares and will receive no proceeds from these resales, but could receive up to approximately $1,117,222 in cash if the pre-funded and other warrants are fully exercised for cash. Common stock outstanding was 17,597,071 shares as of August 31, 2026 and would be 39,242,247 shares assuming full cash exercise of the registered warrants, implying significant potential dilution. Cyabra provides AI- and machine-learning–based tools to detect and analyze online disinformation for government and commercial customers, but reports an accumulated deficit of $61.6 million and recent annual comprehensive losses, expects continued operating losses, faces competition in disinformation detection, and is exposed to Israeli political and security risks and evolving global data-privacy and AI regulations.
Cyabra, Inc. (CYAB) filed an amended resale registration statement covering up to 21,645,176 shares of common stock for selling shareholders, all related to a July 2026 PIPE financing and conversion arrangements for preferred stock. The company is not selling shares in this offering and will not receive proceeds from any resale.
The registration covers already issued shares plus shares issuable from pre-funded warrants, Series A and B warrants, and conversion of preferred shares, much of which requires stockholder approval to become exercisable or convertible. If all related warrants and pre-funded warrants are exercised and preferred shares converted, shares outstanding would rise from 17,597,071 to 39,242,247, implying substantial potential dilution and resale overhang for existing holders.
Cyabra recently completed a SPAC business combination and raised approximately $6 million gross in the PIPE at prices around $0.435 per share or pre-funded warrant, and may receive up to about $1.12 million more in cash if all warrants are exercised. The company focuses on AI- and ML-based disinformation detection, remains an emerging growth company and smaller reporting company, and discloses a history of losses, going-forward capital needs, and significant operational, regulatory, geopolitical, and cybersecurity risks.
Cyabra, Inc. is registering the resale of up to 150,621,827 shares of Common Stock by selling shareholders, including shares issuable upon Pre-Funded Warrants, Series A and Series B Warrants, and upon conversion or exchange of preferred stock. Cyabra itself is not selling shares and receives no proceeds from these resales.
Pre-Funded Warrants are exercisable at $0.0001 per share immediately; Series A Warrants at $0.50 for five years and Series B Warrants at $0.45 for twelve months, each initially exercisable after stockholder approval. Full cash exercises could provide up to approximately $36,409,556 for working capital and other general corporate purposes.
Shares outstanding were 15,765,372 as of July 29, 2026 and would be 166,387,199 assuming full warrant exercise, preferred conversions and the exchange, so the registered shares equal about 955% of current outstanding stock and the company highlights potential substantial dilution and share-price pressure. Cyabra’s AI- and machine-learning-based platform targets online disinformation, but it reports an accumulated deficit of approximately $58.1 million as of March 31, 2026 and total comprehensive losses of $12.8 million in 2025 and $15.6 million in 2024, and states it will require additional capital.